Formycon AG
Developing biosimilar medicines
- B2B
About Formycon AG
Leading developer of high-quality biopharmaceutical medicines, especially biosimilars, in ophthalmology, immunology, and chronic diseases, aiming to increase access to affordable medications
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Belarus
- Founded
- 2012
- Revenue
- €44.5MFY2025, publicly reported
- Website
- formycon.com
- linkedin.com/company/formycon
Formycon AG at a glance
Formycon AG is a B2B company in the Biotechnology Research industry, headquartered in Belarus.
Formycon AG was founded in 2012.
Formycon AG has 51–250 employees.
Formycon AG's revenue is €44.5M (FY2025, publicly reported).
Frequently asked questions about Formycon AG
What is Formycon AG's revenue?
Formycon AG's revenue is €44.5M (FY2025, publicly reported).
How many employees does Formycon AG have?
Formycon AG has 51–250 employees.
Where is Formycon AG headquartered?
Formycon AG is headquartered in Belarus.
Selling to companies like Formycon AG?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies